GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

10293	Companies
213141	Keywords
142921	Articles
112861	Press releases

Home
Companies
GENFIT

BRIEF

published on 04/07/2026 at 19:35, 20 days ago

GENFIT makes available the 2025 Universal Registration Document

AMF Biopharmaceutical Registration Document Liver Diseases GENFIT
BRIEF

published on 04/07/2026 at 19:35, 20 days ago

GENFIT Releases 2025 Universal Registration Document

Liver Diseases GENFIT R&D Portfolio 2025 Registration Document Iqirvo® Approval
PRESS RELEASE

published on 04/07/2026 at 19:30, 20 days ago

GENFIT Announces Publication of the 2025 Universal Registration Document
GENFIT announces the publication of the 2025 Universal Registration Document, providing key financial and corporate governance information. Available for public viewing and download on GENFIT and AMF websites

Biopharmaceutical Company Financial Report Liver Diseases GENFIT 2025 Universal Registration Document
BRIEF

published on 02/12/2026 at 18:40, 2 months 15 days ago

GENFIT welcomes a $20M milestone payment thanks to Iqirvo® performance

Biopharmaceutical GENFIT Ipsen Iqirvo® Stage Payment
BRIEF

published on 02/12/2026 at 18:40, 2 months 15 days ago

GENFIT Secures US$20M Milestone with Iqirvo® Success

Clinical Trials Biopharmaceutical GENFIT Milestone Payment Iqirvo
PRESS RELEASE

published on 02/12/2026 at 18:35, 2 months 15 days ago

GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT receives US$20M milestone from Ipsen as Iqirvo® surpasses US$200M net sales threshold in 2025. Phase 3 in PSC confirmed. CCA Phase 1b study progressing as planned. Financial position reinforced

Net Sales Phase 3 GENFIT Milestone Payment Ipsen
BRIEF

published on 11/10/2025 at 07:50, 5 months 17 days ago

GENFIT Collaborates with EVerZom on Exosome-Based Therapy for Liver Failure

GENFIT ACLF EVerZom Exosome Therapy EViv
PRESS RELEASE

published on 11/10/2025 at 07:45, 5 months 17 days ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
GENFIT collaborates with EVerZom to advance exosome-based regenerative technology in ACLF, aiming for clinical development. The partnership combines expertise in exosome and liver disease research

Exosome GENFIT ACLF EVerZom Regenerative Technology
BRIEF

published on 11/10/2025 at 07:35, 5 months 17 days ago

GENFIT Reveals Encouraging Preclinical Findings on NTZ/G1090N for ACLF Treatment

Preclinical Data GENFIT ACLF Liver Meeting 2025 G1090N
PRESS RELEASE

published on 11/10/2025 at 07:30, 5 months 17 days ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
GENFIT presents promising new preclinical data on NTZ/G1090N for the treatment of ACLF at The Liver Meeting® 2025. G1090N optimizes dosing flexibility for varying patient conditions

Preclinical Data GENFIT NTZ/G1090N ACLF Treatment The Liver Meeting 2025

1 2 ... 7

Accesswire

Published on 04/27/2026 at 17:15, 2 hours 29 minutes ago

SouthGobi Announces Discloseable Transaction Entering Into a Build-Transfer Agreement in Relation to the Dry Coal Separation System
Published on 04/27/2026 at 15:00, 4 hours 44 minutes ago

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Published on 04/27/2026 at 14:25, 5 hours 19 minutes ago

Guanajuato Silver Files Technical Report for Bolanitos Mine
Published on 04/27/2026 at 14:00, 5 hours 44 minutes ago

GameSquare Announces Record Q1 2026 Bookings of Over $10 Million for its GameSquare Experiences Division
Published on 04/27/2026 at 13:00, 6 hours 44 minutes ago

Core Silver and Arcus Development Group Enter into a Binding Letter of Intent for a Business Combination Transaction and Sign a Definitive Option Agreement for the Touleary Project

View all ACCESSWIRE

EQS Group

Published on 04/27/2026 at 19:07, 36 minutes ago

Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
Published on 04/27/2026 at 18:50, 53 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/27/2026 at 18:20, 1 hour 23 minutes ago

Convening Notice of the Company’s Extraordinary General Meeting to be held on 28 May 2026
Published on 04/27/2026 at 18:03, 1 hour 41 minutes ago

Linde Declares Dividend in Second Quarter 2026
Published on 04/27/2026 at 17:45, 1 hour 58 minutes ago

Hikvision releases 2025 full-year and 2026 first-quarter financial results

Les Echos

Published on 04/27/2026 at 17:45, 1 hour 59 minutes ago

Convocation annual general meeting of May 27, 2026
Published on 04/27/2026 at 17:45, 1 hour 59 minutes ago

Weekly share buyback
Published on 04/27/2026 at 17:35, 2 hours 9 minutes ago

Disclosure of transactions in own shares from April 20 to April 24, 2026
Published on 04/27/2026 at 11:42, 8 hours 1 minute ago

Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 24, 2026
Published on 04/24/2026 at 17:45, 3 days 1 hour ago

Share buyback for cancellation

View all LES ECHOS COMFI WIRE